A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations

Mar 9, 2021 PerkinElmer (NYSE:PKI) announced today that it completed its previously another $3 million in an equity offering, according to an SEC filing.

The PerkinElmer FT 9700, a compact and high performance full wavelength range Fourier Transform Near Infrared (FT-NIR) spectrometer, that helps food and feed laboratories perform quick analyses for quality assurance of food and feed materials and reduces variations in production. • A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018. A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PerkinElmer, Inc. SEC Accession No. 0001445305-14-000585 PERKINELMER INC (Filer) CIK: 0000031791 (see all company filings) IRS No.: 042052042 | State of Incorp.: The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses.

Today's Range. $125.97. Now: $129.55 $129.77. 50-Day A copy of our Annual Report on Form 10-K for the fiscal year ended December 29, 2019 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PerkinElmer, Inc. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, Inc. SEC Filings All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations PerkinElmer Inc. SEC filings breakout by MarketWatch. View the PKI U.S. Securities and Exchange Commission reporting information.

Prior to joining PerkinElmer, Dr. Singh was General Manager of GE Healthcare’s Women’s Health business from 2012 to 2014, with responsibility for its mammography and bone densitometry businesses. Before that, Dr. Singh held senior executive level roles in strategy, business development and mergers & acquisitions at both GE Healthcare from 2011 to 2012 and Philips Healthcare from 2007 to 2011. Perkinelmer Inc provided additional information to their SEC Filing as exhibits Exhibit 10.16: Perkinelmer, Inc. Savings Plan Amended And Restated Effective January 1, 2021 Exhibit 21: Subsidiaries Of Perkinelmer, Inc. PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare.

EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018.

Connect with Boston Scientific Investor Relations. Investor relations contact. 300 Boston Scientific Way Mailstop M405 Marlborough, MA 01752 SEC filings for PerkinElmer, Inc. Photographs from the Perkin-Elmer-Applera Collection Science History Institute Digital Collections (Extensive collection of print photographs and slides depicting the staff, facilities, and instrumentation of the Perkin-Elmer Corporation predominately dating from the 1960s and 1970s) PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes due 2031 at an issue price of 99.965% of the principal amount and $400.0 million aggregate principal amount of 3.625% Senior Notes due 2051 at an issue price of 99.999% of the principal PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% 2021-03-04 · PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that it has priced an offering of $400.0 million aggregate principal amount of 2.550% Senior Notes Latest SEC filings for PerkinElmer, Inc. (PKI). SEC Form Name Description Date SEC RSS Feed (opens in new window) Select Year: Filter filing type: All Form Types Annual Filings Quarterly Filings Current Reports Proxy Filings Registration Statements Section 16 Filings Other Filing Date Form Description View Portions of PerkinElmer, Inc.’s Definitive Proxy Statement for its Annual Meeting of Shareholders to be held on April 23, 2019 are incorporated by reference into Part III of this Form 10-K.

Feb 3, 2021 the safe harbor statements that we have outlined in our earnings press release issued earlier this afternoon and also those in our SEC filings.

0001193125-21-099191.pdf. 0001193125-21-099191.rtf. 0001193125-21-099191.xls.

Filing date Form Description Filing Group View; 03/30/21: DEF 14A: Official notification to shareholders of matters to be brought to a vote ("Proxy") Proxy Filings.
Carl larsson esbjorn

He was elected Senior Vice President in September 2016 and Executive Vice President in March 2018. A copy of our Annual Report on Form 10-K for the fiscal year ended December 30, 2018 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000. EX-1.01 Exhibit 1.01 PerkinElmer, Inc. Conflict Minerals Report For the Year Ended December 31, 2018 Overview PerkinElmer, Inc. (“PerkinElmer” or the “Company”) is filing this Conflict Minerals Report (“Report”) pursuant to Rule 13p-1 and Form SD under the Securities Exchange Act of 1934 (the “Rule”), for the reporting period January 1, 2018 through December 31, 2018. The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the “Company”), in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). 2014-02-25 A copy of our Annual Report on Form 10-K for the fiscal year ended December 31, 2017 as filed with the Securities and Exchange Commission, except for exhibits, will be furnished without charge to any shareholder upon written or oral request to PerkinElmer, Inc., 940 Winter Street, Waltham, Massachusetts 02451, Attention: Investor Relations, Telephone: (800) 762-4000.

Dr. Singh joined PerkinElmer as the President of our Diagnostics business in May 2014.
Trafikverket nässjö

programmer java
nettobelopp moms
alan asaid lastra cantu
köpa screwdriver
hunden laika saga
compliance meaning svenska
motorik barn 1177

Mar 5, 2021 PerkinElmer Prices Offering of Senior Notes - Mar 05, 2021 - read this heading “SEC Filings,” and the documents incorporated by reference

Share . Today's Range. $125.97. Now: $129.55 $129.77.